NCT00570011

Low and Conventional Dose of Somatropin in Growth Hormone Deficient Adult Patients

Efficacy of Two Different Dose Regimens of Somatropin in Growth Hormone Deficient Adult Patients

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 112 (actual)
• Sponsor: Eli Lilly and Company · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

An international study in which patients with GHD were randomized to receive somatropin at a dose of either 3 microg/kg/day or 6 microg/kg/day for the first three months. The dose was then doubled (6 microg/kg/day, LD or 12 microg/kg/day, CD) for the next three-months.

Conditions

• Growth Hormone Deficiency

Interventions

Type	Name	Description
DRUG	Somatropin	3 microg/kg/day for the first three months.The dose was then doubled (6 microg/kg/day) for the next three-months.
DRUG	Somatropin	6 microg/kg/day for the first three months. The dose was then doubled (12 microg/kg/day) for the next three-months.

Timeline

• Start date: 1997-06-01
• Completion: 1998-12-01
• First posted: 2007-12-10
• Last updated: 2007-12-11

Locations

1 site across 1 country: United States